Openfund

CORDIS · AIMed

Antimicrobial Integrated Methodologies for orthopaedic applications

Code
AIMed
Programme
H2020
Call
MSCA-ITN-2019
Status
CLOSED
Period
2020-01-01 – 2024-12-31
Total cost (whole consortium)3 845 532 €
EU contribution (whole consortium)3 845 532 €
EU contribution to Bulgarian participants617 127 €

Official data · CORDIS · synced 2026-10-17 10:16 · official record

Participants

OrganisationsRoleCountryGrant
THE UNIVERSITY OF BIRMINGHAMcoordinatorUK909 518 €
ИНСТИТУТ ПО ЕЛЕКТРОНИКА - БАНparticipantBG617 127 €
FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN-NUERNBERGparticipantDE442 380 €
UNIVERSITE DE TOULOUSEparticipantFR274 802 €
INSTITUT NATIONAL POLYTECHNIQUE DE TOULOUSEparticipantFR274 802 €
UNIVERSITE POLYTECHNIQUE HAUTS-DE-FRANCEparticipantFR274 802 €
UNIVERSITA DEGLI STUDI DI TRIESTEparticipantIT261 500 €
PHOTON ENERGY GmbHparticipantDE252 788 €
UNIVERSIDADE DO PORTOparticipantPT237 720 €
RUDER BOSKOVIC INSTITUTEparticipantHR237 367 €
REGEMAT 3D SOCIEDAD LIMITADAparticipantES62 726 €
UNIVERSITY OF LIMERICKparticipantIE0 €

Description

The AIMed network, consisting of 12 beneficiaries and 6 partner organisations, will develop a range of materials with anti-bacterial properties that are suitable for use on the surfaces of orthopaedic implants. This is in response to the increasing problem of post-operative infection by antibiotic-resistant bacteria. By combining several approaches to disrupt surface biofilm formation, the materials developed by the AIMed network will eventually result in fewer surgical infections, faster recovery of patients, and greatly reduced post-operative healthcare costs. The network will develop novel peptide sequences and ways of binding them to the surfaces of olymers, ceramics and metals. A complementary approach will be the developent of metal ion substituted calcium phosphate coatings which can be applied to implants by additive manufacturing techniques. The efficacy of these anti-bacterial surfaces will be further enhanced by laser processing of the material to make it unattractive to biofilms (by altering the roughness and wetting characteristics). The network will carry out a thorough investigation of the properties of the new materials to ensure that they are feasible for use in future implants. This work will include the evaluation of antibacterial action and biocompatibility using appropriate models. Training of the 15 ESR's appointed to the network will be multi-disciplinary and intersectoral, with an emphasis on the need for technology transfer from academic institutions to commercial users.

Official data · CORDIS · synced 2026-10-17 10:16 · official record · Licence: © European Union, CC BY 4.0 (Commission reuse policy).